제약ㆍBIO

제약ㆍBIO

제약ㆍBIO
5G 유통사업
HDPRO
콜드체인
의약품제조

제약ㆍBIO 사업 부문

NewG Lab Pharma는 제약•Bio 사업 부문을 중심으로
First in Class 신약부터 의약품 생산, 유통을 총괄하는 전문제약사로서 성장할 것입니다.

PIPELINE

Pipeline Target Disease Research Pre-Clinical Phase1 Phase2
대사항암제 KAT-101 ATP synthesis inhibition Hepatocellular Carcinoma
Bladder Cancer
Melanoma
Pancreatic Cancer
Leukemia
표적항암제 AB-106 ROS1/NTRT NSCLC
COVID-19치료제 TMPRSS2 inhibition COVID-19
TBD COVID-19 combination drug
Pipeline Target Disease Research Pre-Clinical Phase1 Phase2
대사항암제 KAT-101 ATP synthesis inhibition Hepatocellular Carcinoma
Bladder Cancer
Melanoma
Pancreatic Cancer
Leukemia
표적항암제 AB-106 ROS1/NTRT NSCLC
COVID-19치료제 TMPRSS2 inhibition COVID-19
TBD COVID-19 combination drug